Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology

Efferent Labs Taps Evotec to Advance Implantable Biosensor for R&D, Oncology

FierceBiotech

Efferent Labs has inked a deal with Evotec to develop its implantable biosensor technology. The device, which is injected into a patient or lab animal, contains living cells to measure cellular function in vivo. Click here to read the full article